Giorgio V. Scagliotti, MD, PhD, discusses toxicities related to chemotherapy and surgery in patients with lung cancer.
Giorgio V. Scagliotti, MD, PhD
Advertisement
Articles by Giorgio V. Scagliotti, MD, PhD
Giorgio V. Scagliotti, MD, PhD, from the University of Turin, San Luigi Hospital, Orbassano, Italy, discusses afatinib in patients with EGFR-mutated tumors.
Giorgio V. Scagliotti, MD, PhD, from the University of Turin, discusses recent advances in the molecular genotyping of patients with lung cancer.
Advertisement
Latest Updated Articles
Recent Findings on Molecular Genotyping in Lung CancerPublished: July 25th 2013 | Updated:
Afatinib in Patients With an EGFR MutationPublished: August 28th 2013 | Updated:
Lung Cancer Treatment-Related ToxicitiesPublished: October 14th 2013 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
